Open heart · 2024
Empirical superior vena cava electrical isolation guided by quantitative ablation index improves outcomes of radiofrequency catheter ablation for paroxysmal atrial fibrillation.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Guan Wenchi, Liu Jun, Chen Keping, Yao Yan
Аннотация
BACKGROUND: The value of empirical superior vena cava isolation (SVCI) following pulmonary vein isolation (PVI) to improve the efficacy of radiofrequency catheter ablation (RFCA) for paroxysmal atrial fibrillation (PAF) remains controversial.
OBJECTIVE: To evaluate the efficacy and safety of quantitative ablation index (AI)-guided empirical SVCI, in addition to PVI, for patients with PAF.
METHODS: Patients with symptomatic PAF who underwent RFCA between October 2021 and May 2023 were retrospectively analysed. Patients were categorised into PVI-only group and PVI+SVCI group based on the intraoperative ablation strategy. RFCA was guided by quantitative AI in both groups. Regular clinical follow-ups were conducted to detect AF recurrence, defined as any episode of atrial fibrillation, atrial flutter or atrial tachycardia lasting >30 s.
RESULTS: A total of 246 patients were enrolled, with 108 patients in the PVI group and 138 patients in the PVI+SVCI group. Compared with the PVI group, patients in the PVI+SVCI group had a higher prevalence of coronary artery disease (p=0.04), stroke (p=0.02) and a smaller left atrial diameter (p<0.01). After a follow-up period of 16±6 months, the ablation success rate was significantly higher in the SVCI+PVI group compared with the PVI group (91.3% vs 81.5%, p=0.02). Multivariable logistic regression analysis indicated that SVCI was an independent predictor of reduced AF recurrence postablation (Relative Risk [RR] 0.4, 95% CI 0.19 to 0.90, p=0.026). No significant difference in complication rates was observed between the groups.
CONCLUSION: Quantitative AI-guided empirical SVCI, in addition to PVI, improves the success rate of RFCA for PAF without increasing the risk of complications.
OBJECTIVE: To evaluate the efficacy and safety of quantitative ablation index (AI)-guided empirical SVCI, in addition to PVI, for patients with PAF.
METHODS: Patients with symptomatic PAF who underwent RFCA between October 2021 and May 2023 were retrospectively analysed. Patients were categorised into PVI-only group and PVI+SVCI group based on the intraoperative ablation strategy. RFCA was guided by quantitative AI in both groups. Regular clinical follow-ups were conducted to detect AF recurrence, defined as any episode of atrial fibrillation, atrial flutter or atrial tachycardia lasting >30 s.
RESULTS: A total of 246 patients were enrolled, with 108 patients in the PVI group and 138 patients in the PVI+SVCI group. Compared with the PVI group, patients in the PVI+SVCI group had a higher prevalence of coronary artery disease (p=0.04), stroke (p=0.02) and a smaller left atrial diameter (p<0.01). After a follow-up period of 16±6 months, the ablation success rate was significantly higher in the SVCI+PVI group compared with the PVI group (91.3% vs 81.5%, p=0.02). Multivariable logistic regression analysis indicated that SVCI was an independent predictor of reduced AF recurrence postablation (Relative Risk [RR] 0.4, 95% CI 0.19 to 0.90, p=0.026). No significant difference in complication rates was observed between the groups.
CONCLUSION: Quantitative AI-guided empirical SVCI, in addition to PVI, improves the success rate of RFCA for PAF without increasing the risk of complications.